NR4A1 and breast carcinoma: In breast cancer, for instance, the triple-negative subtype often exhibits relapse within 5 years after surgery, whereas hormone receptor-positive breast cancer may manifest relapses after a decade (Copson et al., 2013; Kennecke et al., 2010; van Maaren et al., 2019).